Yazar "Kücükbay, H" seçeneğine göre listele

Listeleniyor 1 - 3 / 3
  • Küçük Resim Yok
    Öğe
    1-Benzyl-3-(2-phenethyl)benzimidazolium bromide monohydrate
    (Int Union Crystallography, 2005) Akkurt, M; Karaca, S; Kücükbay, H; Orhan, E; Büyükgüngör, O
    The title compound, C22H20N2+center dot Br-center dot H2O, was synthesized from 1-benzylbenzimidazole and 2-bromoethylbenzene in dimethylformamide. The dihedral angle between the two phenyl rings is 70.6 ( 1)degrees. These phenyl rings make dihedral angles of 52.99 ( 9) and 83.03 ( 8)degrees with the benzimidazole ring system. The crystal structure is stabilized by intermolecular C-H center dot center dot center dot Br and O-H center dot center dot center dot Br hydrogen-bond interactions.
  • Küçük Resim Yok
    Öğe
    Antifungal activity of rhodium, iridium, and ruthenium tripodal phosphine complexes
    (Luigi Ponzio E Figlio, 2000) Sülü, M; Kücükbay, H; Durmaz, R; Günal, S
    Twenty-eight rhodium, iridium or ruthenium complexes were evaluated for their in vitro antifungal activities against Candida albicans and Candida tropicalis. Fourteen compounds showed an antifungal activity against C, albicans and C. tropicalis with a range of the minimum inhibitor concentrations (MICs) between 16 and 250 mu g/mL.
  • Küçük Resim Yok
    Öğe
    Synthesis of some heterocyclic phosphonates and their antibacterial and antifungal activities
    (Council Scientific & Industrial Res, 1999) Mete, A; Sener, S; Kücükbay, H; Günal, S; Durmaz, R
    Fifteen heterocyclic phosphonate derivatives and their starting compounds have been evaluated in vitro for antibacterial and antifungal activities against standard strains: Enterococcus faecalis (ATCC 29212), Staphylococcus aureus (ATCC 29213), Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853) and yeast-like fungi; Candida albicans and Candida tropicalis. The compounds newly synthesised have been identified by H-1-NMR, FT-IR and micro analysis. Among the tested compounds 12, 13, 16, 17, 18, 22 and 23 are found effective to inhibit the growth of Candida albicans and Candida tropicalis at the MICs between 100-800 mu g/mL. The compounds tested here generally do not exhibit considerable antibacterial activity at the concentration studied (100-800 mu g/mL), except compound 18 which exhibits antibacterial activity against gram-positive bacteria at the MIC of 400 mu g/mL.